GSA CAPITAL PARTNERS LLP - ARIAD PHARMACEUTICALS INC ownership

ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 2.19 and the average weighting 0.4%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$832,000
+980.5%
60,778
+402.3%
0.04%
+800.0%
Q1 2016$77,000
+16.7%
12,099
+15.4%
0.01%
+66.7%
Q4 2015$66,000
-69.9%
10,484
-60.4%
0.00%
-62.5%
Q2 2015$219,00026,4850.01%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$82,111,00018.09%
Consonance Capital Management LP 5,575,742$35,629,0005.39%
Opaleye Management Inc. 1,250,000$7,988,0004.98%
Tamarack Advisers, LP 1,600,000$10,224,0003.58%
Camber Capital Management LP 5,405,235$34,539,0002.02%
IRONWOOD INVESTMENT MANAGEMENT LLC 324,636$2,074,0001.36%
Palo Alto Investors LP 2,248,317$14,367,0001.12%
1492 Capital Management LLC 202,500$1,294,0001.09%
Geduld E E 120,100$767,0001.05%
JS Capital Management LLC 868,700$5,551,0001.00%
View complete list of ARIAD PHARMACEUTICALS INC shareholders